Introduction: Psoriasis is a chronic inflammatory skin disorder determined by the activation of several immune cells and resident tissue cells. Various cytokines mediate inflammatory signals, including IL-23, which is an important factor involved in the differentiation of T helper (Th17) cells. Areas covered: Increasing evidence suggests that IL-23 is a central cytokine to the pathogenesis of psoriasis. An overview on both experimental and human data will be reported in order to support the hypothesis of a key pathogenic role of IL-23/Th17 axis. Expert opinion: Targeting IL-23 might be a more selective, valid and effective therapeutic approach, which, potentially, may show important advantages in terms of long-term efficacy and safety in the treatment of psoriasis. © 2014 Informa UK, Ltd.

Chiricozzi, A., Saraceno, R., Chimenti, M.s., Guttman Yassky, E., Krueger, J. (2014). Role of IL-23 in the pathogenesis of psoriasis: A novel potential therapeutic target?. EXPERT OPINION ON THERAPEUTIC TARGETS, 18(5), 513-525 [10.1517/14728222.2014.889686].

Role of IL-23 in the pathogenesis of psoriasis: A novel potential therapeutic target?

CHIRICOZZI, ANDREA;SARACENO, ROSITA;CHIMENTI, MARIA SOLE;
2014-01-01

Abstract

Introduction: Psoriasis is a chronic inflammatory skin disorder determined by the activation of several immune cells and resident tissue cells. Various cytokines mediate inflammatory signals, including IL-23, which is an important factor involved in the differentiation of T helper (Th17) cells. Areas covered: Increasing evidence suggests that IL-23 is a central cytokine to the pathogenesis of psoriasis. An overview on both experimental and human data will be reported in order to support the hypothesis of a key pathogenic role of IL-23/Th17 axis. Expert opinion: Targeting IL-23 might be a more selective, valid and effective therapeutic approach, which, potentially, may show important advantages in terms of long-term efficacy and safety in the treatment of psoriasis. © 2014 Informa UK, Ltd.
2014
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
English
Anti-p19; Biologics; Guselkumab; IL-17; IL-23; IL-23p19; Psoriasis; Th17; Tildrakizumab; Animals; Antibodies, Monoclonal; Antigen-Presenting Cells; Bacterial Infections; Cell Differentiation; Clinical Trials as Topic; Cytokines; Drug Evaluation, Preclinical; Genetic Predisposition to Disease; Humans; Interleukin-12 Subunit p40; Interleukin-23; Interleukin-23 Subunit p19; Keratinocytes; Mice; Mice, Knockout; Psoriasis; Receptors, Interleukin; Signal Transduction; T-Lymphocyte Subsets; Th17 Cells; Molecular Targeted Therapy; Drug Discovery3003 Pharmaceutical Science; Pharmacology; Clinical Biochemistry; Molecular Medicine; Medicine (all)
http://www.informapharmascience.com/loi/ett
Chiricozzi, A., Saraceno, R., Chimenti, M.s., Guttman Yassky, E., Krueger, J. (2014). Role of IL-23 in the pathogenesis of psoriasis: A novel potential therapeutic target?. EXPERT OPINION ON THERAPEUTIC TARGETS, 18(5), 513-525 [10.1517/14728222.2014.889686].
Chiricozzi, A; Saraceno, R; Chimenti, Ms; Guttman Yassky, E; Krueger, J
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/119599
Citazioni
  • ???jsp.display-item.citation.pmc??? 13
  • Scopus 53
  • ???jsp.display-item.citation.isi??? 49
social impact